Archive | Interviews RSS feed for this section

A Match Made at RESI: Part I

20 May

By Rory McCann, Marketing Manager & Conference Producer, LSN

Michele Marzola is a prolific investor and entrepreneur in healthcare with a career that spans decades. He knows exceptional technology when he sees it and a powerful team when he meets them, so when he met Antoine Prestat, founder of PEP-Therapy at RESI March 2020, he knew he’d found something special.

In Part I of our two-part interview about Michele’s investment in PEP-Therapy, we discuss his process when sourcing assets, due diligence, digital partnering, and his best advice to fundraising entrepreneurs.

 

There’s still time to sign up for Digital RESI June! Register today to start booking meetings with over 350 investors.  

Stories for a New Age

6 May

By Rory McCann, Marketing Manager & Conference Producer, LSN

When LifeBio Founder and CEO, Beth Sanders started telling stories, she knew how influential they could be. Today, patients and healthcare providers are using LifeBio’s storytelling platform to connect, decrease loneliness, and promote better care and overall wellness.

LifeBio was a winner at the March Innovator’s Pitch Challenge at Longevity, Health & Innovation (now RESI Longevity). Registration for RESI Longevity (September 16-17) is now open at super early bird rates until July 23, and applications for the next Innovator’s Pitch Challenge are open!

Listen to our conversation with Beth on the origin and mission of LifeBio, and how stories are having a strong impact on today’s seniors and the healthcare system.

The Roles of a Lifetime

29 Apr

By Rory McCann, Marketing Manager & Conference Producer, LSN

Eran is very active in the world of early-stage startups and fundraising within life science and is a recent contributor to the Redefining Early Stage Investments (RESI) community. Eran speaks with us about the value he’s found at RESI and how his many roles helped him make the most of his experience and add value to others. 

Digital RESI takes place June 8-10. There’s still time to save on early bird rates, sign up by May 7 to save!

A Perfect Match: CEO Successfully Navigates Early-Stage Investment

22 Apr

By Rory McCann, Marketing Manager & Conference Producer, LSN

APIE Therapeutics is an early-stage company developing vascular endothelium niche repair and regeneration. We spoke with CEO, Dr. Esther Alegría about the early days of APIE Therapeutics and the importance of fit when seeking capital and building a powerful team.

APIE Therapeutics is an Innovator’s Pitch Challenge winner at last month’s Longevity, Health & Innovation, a Redefining Early Stage Investments (RESI) partnering event. Learn more about RESI and sign up by May 7 to save $50 on early bird rates.

RESI Longevity, September 16-17, is now accepting Innovator’s Pitch Challenge applications. Learn more and sign up by July 23 to save!

Patents, Profiles, Patience, and the Power of a Good “No”: The Panaceutics Rx Story

15 Apr

By Rory McCann, Marketing Manager & Conference Producer, LSN

Panaceutics Rx is an early-stage company advancing accessible personalized medicine based on patients’ digital health profiles using robotic platforms and patented processes.

We spoke with Panaceutics CEO, Edison Hudson about the need for more accessible adherence to life-saving therapies and Panaceutics’ approach to working with hospitals, investors, and physicians.

Panaceutics Rx is an Innovator’s Pitch Challenge winner at last month’s Longevity, Health & Innovation, a Redefining Early Stage Investments (RESI) partnering event. Learn more about RESI and sign up by May 7 to save $50 on early bird rates.

Starting with Pep: An Early-Stage Conversation with Creative Bio-Peptides

8 Apr

By Rory McCann, Marketing Manager & Conference Producer, LSN

Creative Bio-Peptides is an early-stage company, founded and led by Dr. Michael Ruff, with a mission to improve lives through developing oral receptor-active peptides targeting neurodegenerative diseases. We spoke with Chief Business Officer, Michael Simon about the early-stage journey of Creative Bio-Peptides – how it was started, what their strategy looks like today, and where they see the company going forward.

Creative Bio-Peptides is a past participant at an Redefining Early Stage Investments (RESI) partnering event. Learn more about RESI and sign up by April 9 to save $100 on super early bird rates.

What Successful Partnering Really Looks Like: A Conversation with Neuro20 Technologies

18 Feb

By Rory McCann, Marketing Manager & Conference Producer, LSN

When fundraising executives seek out a successful partnering experience, so many define success with deals and checks. At Life Science Nation, we frequently hear success stories that do end with capital and funding, but many do not. Instead, these stories touch on the benefits of successful partnering that impact company growth and bottom line in other ways, often the details that are taken for granted when seeking strategic partners.

Neuro20 Technologies is one such success story. They attended their first digital RESI conference looking for capital but came out with so much more. Listen to their story, and sign up for RESI (March 15-17) and 4D Meets AI (March 18-19) to learn more from the Neuro20 Technologies team and start your partnering success story!

%d bloggers like this: